Innova Captab Ltd Q1 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/y3vhqte3c6q9ueufarmit5gz.pdf

Key Takeaways


Jammu Ramp-Up

Lokesh Bhasin: "Jammu, Jammu ramp-up is pacing up the way we expected. So, we should also consider that normally quarter one, there is a seasonal impact of the entire year. And from, see, from Q2 onwards the normal healthy season start picking up."

Segment Performance

Lokesh Bhasin: "So, from a plant perspective, from a manufacturing capability business, this our branded generic business is just considered as a normal CDMO customer by our plant. So, from that particular viewpoint, there is no, I would say, additional treatment or any special treatment for our branded generic business."

Margins & Cost Structure

Margin componentLevel
Consolidated margin~16%
Non-Jammu margin~20%
Jammu margin1% to 1.5%
Gross margin (Q1)~35.5%
Vinay Lohariwala: "Assuming 20% is very high expectation. I think it 17%, 18% is the fair number."

Growth Drivers & Strategy

Vinay Lohariwala: "Both the engine can help the company to grow or maintain this 20% plus CAGR in the future."

Capex & Investment


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth20% revenue growth, profitability outpacing revenueFY27
Volume growthNorth of 20% on volume basisFY27
Margin15% to 16% plus-minus 2%FY27
Gross margin~35.5% plus/minus 2%FY27
Jammu revenue₹1,400 crore optimum at 65–70% utilizationNo date
Jammu margin17% to 18% margin profileNo date
Jammu approvalsProduct approvals from different marketsBy end of FY27
Maintenance capex₹20 crore to ₹25 croreFY27 and FY28
Growth capex₹20 crore to ₹30 croreFY27 and FY28
R&D spend0.7% to 1% of total revenueFY27
Cash conversion cycle90 days plus/minus 10 daysGroup level, ongoing
Sharon growthEarly teens, in line with organic businessFY27

Key Metrics

MetricQ1 FY27
Revenue₹470.9 crores, +34% YoY
EBITDA₹75.1 crores, +33% YoY, margin of 16%
Profit after tax₹44.1 crores, +42% YoY
Gross margin~35.5%, down 1% to 1.5% YoY; full-year expected at 35.5% plus/minus 2%
CDMO revenue₹328.7 crores, +32% YoY
Branded generic revenue₹142.2 crores, +39% YoY
Export share of revenue32% of consolidated revenue
Volume growth guidance20% plus on volume basis, maintained for FY27
Jammu facility revenue~₹107 crores, up from ~₹90 crores in Q4 FY26
Jammu facility utilization~25% to 30% on an annualized basis
Jammu facility EBITDA₹1 crore to ₹1.5 crores, first positive quarter
Jammu optimum revenue potential₹1,400 crores at 65% to 70% utilization
Cash conversion cycle90 days, plus/minus 10 days at group level
R&D spend~0.7% to 1% of total revenue
Maintenance capex₹20 crores to ₹25 crores annually for FY27 and FY28
Growth capex₹20 crores to ₹30 crores annually for existing capability augmentation or debottlenecking